跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-DULOXETINE
Authorized
STANDARD
MAR-DULOXETINE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
88b922198ea273ce
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
88b922198ea273ce
Drug Approval Canada Name
MAR-DULOXETINE
Product Name
MAR-DULOXETINE
Status
Marketed
Status Date
2019-05-14
Original Market Date
2016-05-10
Din
02446081
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
88b922198ea273ce
Type
Standard
Back to Health Canada Approvals